Modeling Huntington's Disease in Cells, Flies, and Mice
- 1 January 2001
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 23 (1) , 21-52
- https://doi.org/10.1385/mn:23:1:21
Abstract
A milestone in Huntington’s disease (HD) research is represented by the identification of the causative gene. With the genetics at hand, a series of transgenic cellular and animal models has been developed, which has greatly contributed to understanding of HD. All these models are described in this review, and are compared to each other, along with the information they have generated. Although the mechanism by which progressive loss of striatal neurons occurs in HD remains uncertain, hypotheses on mutant huntingtin toxicity involve impaired vescicular trafficking, transcriptional dysregulation, and/or activation of apoptotic pathways. The development of inducible HD mice has shown that neurodegeneration in HD may be at least partially blocked. Although traditionally considered a “gain-of-function” disease, the recent finding that normal huntingtin has an important role in neuronal survival suggests that loss of function of the normal protein might contribute to HD as well, also discloseing new perspectives on the therapeutical approach to the pathology.Keywords
This publication has 100 references indexed in Scilit:
- Wild-Type and Mutant Huntingtins Function in Vesicle Trafficking in the Secretory and Endocytic PathwaysExperimental Neurology, 1998
- Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansionNature Genetics, 1997
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Activation of the JAK/STAT Pathway Leads to Proliferation of ST14A Central Nervous System Progenitor CellsJournal of Biological Chemistry, 1996
- HEAT repeats in the Huntington's disease proteinNature Genetics, 1995
- Expression of the Huntington disease gene in rodents: cloning the rat homologue and evidence for downregulation in non-neuronal tissues during developmentHuman Molecular Genetics, 1995
- Structural analysis of the 5′ region of mouse and human huntington disease genes reveals conservation of putative promoter region and di- and trinucleotide polymorphismsGenomics, 1995
- Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat numberHuman Molecular Genetics, 1993
- Differential 3′ polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expressionHuman Molecular Genetics, 1993
- Abnormalities of Striatal Projection Neurons andN-Methyl-D-Aspartate Receptors in Presymptomatic Huntington's DiseaseNew England Journal of Medicine, 1990